Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of EBPL mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | decreases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of EBPL mRNA | CTD | PMID:22206623 | 1,3-dinitrobenzene | decreases expression | ISO | Ebpl (Rattus norvegicus) | 6480464 | 3-dinitrobenzene results in decreased expression of EBPL mRNA | CTD | PMID:21983209 | 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EBPL mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | increases expression | ISO | Ebpl (Rattus norvegicus) | 6480464 | Ethinyl Estradiol results in increased expression of EBPL mRNA | CTD | PMID:17557909 | 17beta-estradiol | multiple interactions | ISO | EBPL (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of EBPL mRNA | CTD | PMID:30165855 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EBPL mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Ebpl (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of EBPL mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of EBPL mRNA | CTD | PMID:21570461 and PMID:26377647 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of EBPL mRNA | CTD | PMID:17949056 | 6-propyl-2-thiouracil | decreases expression | ISO | Ebpl (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of EBPL mRNA | CTD | PMID:25825206 | all-trans-retinoic acid | decreases expression | ISO | EBPL (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of EBPL mRNA | CTD | PMID:33167477 | aristolochic acid A | decreases expression | ISO | EBPL (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of EBPL mRNA | CTD | PMID:33212167 | Aroclor 1254 | increases expression | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of EBPL mRNA | CTD | PMID:23650126 | benzo[a]pyrene | decreases expression | ISO | EBPL (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of EBPL mRNA | CTD | PMID:20064835 | benzo[a]pyrene | decreases methylation | ISO | EBPL (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of EBPL promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of EBPL mRNA | CTD | PMID:22228805 | benzo[a]pyrene | multiple interactions | EXP | | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of EBPL mRNA] | CTD | PMID:22228805 | bisphenol A | decreases expression | ISO | Ebpl (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of EBPL mRNA | CTD | PMID:25181051 and PMID:34947998 | caffeine | decreases expression | ISO | Ebpl (Rattus norvegicus) | 6480464 | Caffeine results in decreased expression of EBPL mRNA | CTD | PMID:20864626 | carbon nanotube | decreases expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | CGP 52608 | multiple interactions | ISO | EBPL (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to EBPL gene] | CTD | PMID:28238834 | choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EBPL gene | CTD | PMID:20938992 | cisplatin | decreases expression | ISO | EBPL (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of EBPL mRNA | CTD | PMID:27594783 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of EBPL mRNA | CTD | PMID:19770486 | disodium selenite | increases expression | ISO | EBPL (Homo sapiens) | 6480464 | Sodium Selenite results in increased expression of EBPL mRNA | CTD | PMID:18175754 | entinostat | increases expression | ISO | EBPL (Homo sapiens) | 6480464 | entinostat results in increased expression of EBPL mRNA | CTD | PMID:27188386 | flutamide | decreases expression | ISO | Ebpl (Rattus norvegicus) | 6480464 | Flutamide results in decreased expression of EBPL mRNA | CTD | PMID:24793618 | folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EBPL gene | CTD | PMID:20938992 | formaldehyde | decreases expression | ISO | EBPL (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of EBPL mRNA | CTD | PMID:23649840 | gallic acid | decreases expression | ISO | EBPL (Homo sapiens) | 6480464 | Gallic Acid results in decreased expression of EBPL mRNA | CTD | PMID:34408198 | inulin | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of EBPL mRNA | CTD | PMID:36331819 | ketamine | decreases expression | ISO | Ebpl (Rattus norvegicus) | 6480464 | Ketamine results in decreased expression of EBPL mRNA | CTD | PMID:20080153 | L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EBPL gene | CTD | PMID:20938992 | lead diacetate | decreases expression | ISO | Ebpl (Rattus norvegicus) | 6480464 | lead acetate results in decreased expression of EBPL mRNA | CTD | PMID:22641619 | methoxyacetic acid | decreases expression | ISO | Ebpl (Rattus norvegicus) | 6480464 | methoxyacetic acid results in decreased expression of EBPL mRNA | CTD | PMID:20864626 | methyl methanesulfonate | decreases expression | ISO | EBPL (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of EBPL mRNA | CTD | PMID:23649840 | methylmercury chloride | decreases expression | ISO | Ebpl (Rattus norvegicus) | 6480464 | methylmercuric chloride results in decreased expression of EBPL mRNA | CTD | PMID:20864626 | Monobutylphthalate | decreases expression | ISO | Ebpl (Rattus norvegicus) | 6480464 | monobutyl phthalate results in decreased expression of EBPL mRNA | CTD | PMID:20864626 | N-nitrosodiethylamine | multiple interactions | ISO | Ebpl (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of EBPL mRNA and [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of EBPL promoter | CTD | PMID:25374375 | nefazodone | increases expression | ISO | Ebpl (Rattus norvegicus) | 6480464 | nefazodone results in increased expression of EBPL mRNA | CTD | PMID:24136188 | nimesulide | increases expression | ISO | Ebpl (Rattus norvegicus) | 6480464 | nimesulide results in increased expression of EBPL mRNA | CTD | PMID:24136188 | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of EBPL mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | ISO | EBPL (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of EBPL mRNA | CTD | PMID:29067470 | pentachlorophenol | decreases expression | EXP | | 6480464 | Pentachlorophenol results in decreased expression of EBPL mRNA | CTD | PMID:23892564 | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of EBPL mRNA more ... | CTD | PMID:36331819 | phenobarbital | multiple interactions | ISO | Ebpl (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of EBPL mRNA and [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of EBPL promoter | CTD | PMID:25374375 | phenytoin | increases expression | ISO | Ebpl (Rattus norvegicus) | 6480464 | Phenytoin results in increased expression of EBPL mRNA | CTD | PMID:20345932 | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of EBPL mRNA | CTD | PMID:18301758 | temozolomide | increases expression | ISO | EBPL (Homo sapiens) | 6480464 | Temozolomide results in increased expression of EBPL mRNA | CTD | PMID:31758290 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of EBPL mRNA | CTD | PMID:27339419 and PMID:31919559 | trichloroethene | decreases expression | ISO | Ebpl (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of EBPL mRNA | CTD | PMID:33387578 | tungsten | increases expression | EXP | | 6480464 | Tungsten results in increased expression of EBPL mRNA | CTD | PMID:30912803 | urethane | decreases expression | ISO | EBPL (Homo sapiens) | 6480464 | Urethane results in decreased expression of EBPL mRNA | CTD | PMID:28818685 | valdecoxib | increases expression | ISO | Ebpl (Rattus norvegicus) | 6480464 | valdecoxib results in increased expression of EBPL mRNA | CTD | PMID:24136188 | valproic acid | decreases expression | ISO | EBPL (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of EBPL mRNA | CTD | PMID:23179753 | vinclozolin | increases expression | ISO | Ebpl (Rattus norvegicus) | 6480464 | vinclozolin results in increased expression of EBPL mRNA | CTD | PMID:22570695 | |